Innate immune system modulation
Search documents
Revelation Biosciences(REVB) - Prospectus(update)
2024-01-30 20:32
As filed with the U.S. Securities and Exchange Commission on January 30, 2024. Registration No. 333-276232 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________ Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 4660 La Jolla Village Drive, Suite 100, San Diego, CA 92122 __________________________________________ REVELATION BIOSCIENCES, INC. (Exact name of registrant as specified in its charter) ___________________ ...
Revelation Biosciences(REVB) - Prospectus(update)
2024-01-29 22:32
As filed with the U.S. Securities and Exchange Commission on January 29, 2024. Registration No. 333-276232 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________ (Jurisdiction of incorporation or organization) Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________________________ REVELATION BIOSCIENCES, INC. (Primary Standard Industrial Classification Code Number) (Exact name of registrant as ...
Revelation Biosciences(REVB) - Prospectus
2023-12-22 18:23
As filed with the U.S. Securities and Exchange Commission on December 22, 2023. Registration No. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________ FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________________________ REVELATION BIOSCIENCES, INC. (Exact name of registrant as specified in its charter) __________________________________________ DELAWARE (Jurisdiction of incorporation or organization) 2834 84- ...